The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Alternative splicing and cancer: a systematic review
Open accessAbstract
The abnormal regulation of alternative splicing is usually accompanied by the occurrence and development of tumors, which would produce multiple different isoforms and diversify protein expression. The aim of the present study was to conduct a systematic review in order to describe the regulatory mechanisms of alternative splicing, as well as its functions in tumor cells, from proliferation and apoptosis to invasion and metastasis, and from angiogenesis to metabolism. The abnormal splicing events contributed to tumor progression as oncogenic drivers and/or bystander factors. The alterations in splicing factors detected in tumors and other mis-splicing events (i.e., long non-coding and circular RNAs) in tumorigenesis were also included. The findings of recent therapeutic approaches targeting splicing catalysis and splicing regulatory proteins to modulate pathogenically spliced events (including tumor-specific neo-antigens for cancer immunotherapy) were introduced. The emerging RNA-based strategies for the treatment of cancer with abnormally alternative splicing isoforms were also discussed. However, further studies are still required to address the association between alternative splicing and cancer in more detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Pan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
circRNA biogenesis competes with pre-mRNA splicing
Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.019 · Cited by 3,083 · cited 1×
“Furthermore, circRNAs biogenesis may compete with pre-mRNA maturation, thus decreasing the levels of linear mRNAs that harbor circularized exons.(175) In addition, circRNAs can function as sponges for microRNAs (miRNAs)(176) to sequester normal functional miRNA.”
BackgroundExon-intron circular RNAs regulate transcription in the nucleus
Li, Z., Huang, C., Bao, C., Chen, L., Lin, M., Wang, X., Zhong, G., Yu, B., Hu, W., Dai, L., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2959 · Cited by 2,905
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Mechanisms of Alternative Pre-Messenger RNA Splicing
Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Circular intronic long noncoding RNAs
Zhang, Y., Zhang, X.-O., Chen, T., Xiang, J.-F., Yin, Q.-F., Xing, Y.-H., Zhu, S., Yang, L., & Chen, L.-L. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.017 · Cited by 2,221
Self-citationExpansion of the eukaryotic proteome by alternative splicing
Nilsen, T. W., & Graveley, B. R. (2010) · Nature · doi:10.1038/nature08909 · Cited by 2,197
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B. M., Strein, C., Davey, N. E., Humphreys, D. T., Preiss, T., Steinmetz, L. M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.031 · Cited by 2,132
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093
Extensive translation of circular RNAs driven by N6-methyladenosine
Yang, Y., Fan, X., Mao, M., Song, X., Wu, P., Zhang, Y., Jin, Y., Yang, Y., Chen, L.-L., Wang, Y., et al. (2017) · Cell Research · doi:10.1038/cr.2017.31 · Cited by 1,855
Self-citationMapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
The biogenesis and emerging roles of circular RNAs
Chen, L.-L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.32 · Cited by 1,743
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw027 · Cited by 1,699
CircRNA: functions and properties of a novel potential biomarker for cancer
Meng, S., Zhou, H., Feng, Z., Xu, Z., Tang, Y., Li, P., & Wu, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0663-2 · Cited by 1,521
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Spliced segments at the 5′ terminus of adenovirus 2 late mRNA
Berget, S. M., Moore, C., & Sharp, P. A. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3171 · Cited by 1,413
The functions and unique features of long intergenic non-coding RNA
Ransohoff, J. D., Wei, Y., & Khavari, P. A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.104 · Cited by 1,330
Circular RNAs in cancer: opportunities and challenges in the field
Kristensen, L. S., Hansen, T. B., Venø, M. T., & Kjems, J. (2018) · Oncogene · doi:10.1038/onc.2017.361 · Cited by 1,326
Understanding alternative splicing: towards a cellular code
Matlin, A. J., Clark, F., & Smith, C. W. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1645 · Cited by 1,305
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Lee, Y., & Rio, D. C. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034316 · Cited by 1,291
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Chen, M., & Manley, J. L. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2777 · Cited by 1,284
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
CRISPR/Cas9 in Genome Editing and Beyond
Wang, H., La Russa, M., & Qi, L. S. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014607 · Cited by 1,110
Regulation of Alternative Splicing by Histone Modifications
Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M., & Misteli, T. (2010) · Science · doi:10.1126/science.1184208 · Cited by 1,109
The hnRNP family: insights into their role in health and disease
Geuens, T., Bouhy, D., & Timmerman, V. (2016) · Human Genetics · doi:10.1007/s00439-016-1683-5 · Cited by 1,093
Context-dependent control of alternative splicing by RNA-binding proteins
Fu, X.-D., & Ares, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3778 · Cited by 1,044 · cited 3×
“For example, in the process of spliceosome assembly and catalysis, the activity of SR proteins is usually regulated by phosphorylation.(23) SRPKs in the cytoplasm and CDC-like kinases in the nucleus are two families of kinases involved in the regulation of SR-protein phosphorylation.”
BackgroundDiverse alternative back-splicing and alternative splicing landscape of circular RNAs
Zhang, X.-O., Dong, R., Zhang, Y., Zhang, J.-L., Luo, Z., Zhang, J., Chen, L.-L., & Yang, L. (2016) · Genome Research · doi:10.1101/gr.202895.115 · Cited by 1,029
Self-citationQuesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
Jurica, M. S., & Moore, M. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00270-3 · Cited by 962
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Kahles, A., Lehmann, K.-V., Toussaint, N. C., Hüser, M., Stark, S. G., Sachsenberg, T., Stegle, O., Kohlbacher, O., Sander, C., Caesar-Johnson, S. J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.001 · Cited by 897
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus
Fu, X.-D., & Maniatis, T. (1990) · Nature · doi:10.1038/343437a0 · Cited by 731
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E., Abdel-Wahab, O., & Bradley, R. K. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.51 · Cited by 687
Efficient backsplicing produces translatable circular mRNAs
Wang, Y., & Wang, Z. (2015) · RNA · doi:10.1261/rna.048272.114 · Cited by 668
Hallmarks of alternative splicing in cancer
Oltean, S., & Bates, D. O. (2014) · Oncogene · doi:10.1038/onc.2013.533 · Cited by 664
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing
Guo, W., Schafer, S., Greaser, M. L., Radke, M. H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2693 · Cited by 589
The Functional Impact of Alternative Splicing in Cancer
Climente-González, H., Porta-Pardo, E., Godzik, A., & Eyras, E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.012 · Cited by 552
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Itzykson, R., Kosmider, O., Renneville, A., Gelsi-Boyer, V., Meggendorfer, M., Morabito, M., Berthon, C., Adès, L., Fenaux, P., Beyne-Rauzy, O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3314 · Cited by 545
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
Seiler, M., Yoshimi, A., Darman, R., Chan, B., Keaney, G., Thomas, M., Agrawal, A. A., Caleb, B., Csibi, A., Sean, E., et al. (2018) · Nature Medicine · doi:10.1038/nm.4493 · Cited by 507
Reversing a model of Parkinson's disease with in situ converted nigral neurons
Qian, H., Kang, X., Hu, J., Zhang, D., Liang, Z., Meng, F., Zhang, X., Xue, Y., Maimon, R., Dowdy, S. F., et al. (2020) · Nature · doi:10.1038/s41586-020-2388-4 · Cited by 480
Regulation of splicing by SR proteins and SR protein-specific kinases
Zhou, Z., & Fu, X.-D. (2013) · Chromosoma · doi:10.1007/s00412-013-0407-z · Cited by 478
Functional recognition of the 3′ splice site AG by the splicing factor U2AF35
Wu, S., Romfo, C. M., Nilsen, T. W., & Green, M. R. (1999) · Nature · doi:10.1038/45590 · Cited by 457
Regulation of Alternative Splicing Through Coupling with Transcription and Chromatin Structure
Naftelberg, S., Schor, I. E., Ast, G., & Kornblihtt, A. R. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034242 · Cited by 448
Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447
Mechanisms of programmed cell death in the developing brain
Kuan, C.-Y., Roth, K. A., Flavell, R. A., & Rakic, P. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01581-2 · Cited by 443
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
Zhou, H., Su, J., Hu, X., Zhou, C., Li, H., Chen, Z., Xiao, Q., Wang, B., Wu, W., Sun, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.024 · Cited by 437
Self-citationSF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jädersten, M., Jansson, M., Elena, C., Gallì, A., Walldin, G., Della Porta, M. G., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633537 · Cited by 434
The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate
Jurica, M. S., Mesecar, A., Heath, P. J., Shi, W., Nowak, T., & Stoddard, B. L. (1998) · Structure · doi:10.1016/s0969-2126(98)00021-5 · Cited by 426
The spliceosome as a target of novel antitumour drugs
Bonnal, S., Vigevani, L., & Valcárcel, J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3823 · Cited by 405
Evolution of SR protein and hnRNP splicing regulatory factors
Busch, A., & Hertel, K. J. (2012) · WIREs RNA · doi:10.1002/wrna.100 · Cited by 394
Ji, Q., Zhang, L., Liu, X., Zhou, L., Wang, W., Han, Z., Sui, H., Tang, Y., Wang, Y., Liu, N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.383 · Cited by 381
Bechara, E. G., Sebestyén, E., Bernardis, I., Eyras, E., & Valcárcel, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.010 · Cited by 372
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Makishima, H., Visconte, V., Sakaguchi, H., Jankowska, A. M., Abu Kar, S., Jerez, A., Przychodzen, B., Bupathi, M., Guinta, K., Afable, M. G., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399774 · Cited by 370
A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression
Grelet, S., Link, L. A., Howley, B., Obellianne, C., Palanisamy, V., Gangaraju, V. K., Diehl, J. A., & Howe, P. H. (2017) · Nature Cell Biology · doi:10.1038/ncb3595 · Cited by 357
Alternative tumour-specific antigens
Smith, C. C., Selitsky, S. R., Chai, S., Armistead, P. M., Vincent, B. G., & Serody, J. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0162-4 · Cited by 351
Structure of a yeast spliceosome at 3.6-angstrom resolution
Yan, C., Hang, J., Wan, R., Huang, M., Wong, C. C. L., & Shi, Y. (2015) · Science · doi:10.1126/science.aac7629 · Cited by 334
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs
Sureau, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1785 · Cited by 310
Splicing regulation by long noncoding RNAs
Romero-Barrios, N., Legascue, M. F., Benhamed, M., Ariel, F., & Crespi, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky095 · Cited by 310
Splicing-factor alterations in cancers
Anczuków, O., & Krainer, A. R. (2016) · RNA · doi:10.1261/rna.057919.116 · Cited by 302
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Shirai, C. L., Ley, J. N., White, B. S., Kim, S., Tibbitts, J., Shao, J., Ndonwi, M., Wadugu, B., Duncavage, E. J., Okeyo-Owuor, T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.008 · Cited by 287
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284
Ordered and Dynamic Assembly of Single Spliceosomes
Hoskins, A. A., Friedman, L. J., Gallagher, S. S., Crawford, D. J., Anderson, E. G., Wombacher, R., Ramirez, N., Cornish, V. W., Gelles, J., & Moore, M. J. (2011) · Science · doi:10.1126/science.1198830 · Cited by 277
Zhou, Z., Qiu, J., Liu, W., Zhou, Y., Plocinik, R. M., Li, H., Hu, Q., Ghosh, G., Adams, J. A., Rosenfeld, M. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.014 · Cited by 273
Alternative splicing: an emerging topic in molecular and clinical oncology
Pajares, M. J., Ezponda, T., Catena, R., Calvo, A., Pio, R., & Montuenga, L. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70104-3 · Cited by 267
Structure of a yeast activated spliceosome at 3.5 Å resolution
Yan, C., Wan, R., Bai, R., Huang, G., & Shi, Y. (2016) · Science · doi:10.1126/science.aag0291 · Cited by 261
Alternative mRNA splicing in cancer immunotherapy
Frankiw, L., Baltimore, D., & Li, G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0195-7 · Cited by 248
The RNAissance family: SR proteins as multifaceted regulators of gene expression
Howard, J. M., & Sanford, J. R. (2015) · WIREs RNA · doi:10.1002/wrna.1260 · Cited by 247
Massone, S., Vassallo, I., Fiorino, G., Castelnuovo, M., Barbieri, F., Borghi, R., Tabaton, M., Robello, M., Gatta, E., Russo, C., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.019 · Cited by 240
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato-Otsubo, A., Kohlmann, A., Sanada, M., Grossmann, V., Sundaresan, J., Shiraishi, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7042 · Cited by 240
Chen, M., Zhang, J., & Manley, J. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2513 · Cited by 236
Damm, F., Kosmider, O., Gelsi-Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della Valle, V., Couronné, L., Scourzic, L., Chesnais, V., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400994 · Cited by 231
Spliceosomal disruption of the non-canonical BAF complex in cancer
Inoue, D., Chew, G.-L., Liu, B., Michel, B. C., Pangallo, J., D’Avino, A. R., Hitchman, T., North, K., Lee, S. C.-W., Bitner, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1646-9 · Cited by 229
Xu, Y., Gao, X. D., Lee, J.-H., Huang, H., Tan, H., Ahn, J., Reinke, L. M., Peter, M. E., Feng, Y., Gius, D., et al. (2014) · Genes & Development · doi:10.1101/gad.241968.114 · Cited by 225
Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling
Lee, G., Zheng, Y., Cho, S., Jang, C., England, C., Dempsey, J. M., Yu, Y., Liu, X., He, L., Cavaliere, P. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.037 · Cited by 222
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities
Zhang, J., Lieu, Y. K., Ali, A. M., Penson, A., Reggio, K. S., Rabadan, R., Raza, A., Mukherjee, S., & Manley, J. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514105112 · Cited by 208
Kong, J., Sun, W., Li, C., Wan, L., Wang, S., Wu, Y., Xu, E., Zhang, H., & Lai, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.015 · Cited by 208
Wang, L., Brooks, A. N., Fan, J., Wan, Y., Gambe, R., Li, S., Hergert, S., Yin, S., Freeman, S. S., Levin, J. Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.005 · Cited by 207
SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control
Sun, S., Zhang, Z., Sinha, R., Karni, R., & Krainer, A. R. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1750 · Cited by 201
BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells
Zhou, X., Li, X., Cheng, Y., Wu, W., Xie, Z., Xi, Q., Han, J., Wu, G., Fang, J., & Feng, Y. (2014) · Nature Communications · doi:10.1038/ncomms5581 · Cited by 194
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway
Weg-Remers, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4194 · Cited by 184
The long noncoding RNA RNCR2 directs mouse retinal cell specification
Rapicavoli, N. A., Poth, E. M., & Blackshaw, S. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-49 · Cited by 184
Therapeutic Potential of Splice-Switching Oligonucleotides
Bauman, J. A., Jearawiriyapaisarn, N., & Kole, R. (2009) · Oligonucleotides · doi:10.1089/oli.2008.0161 · Cited by 174
Structure of a yeast catalytic step I spliceosome at 3.4 Å resolution
Wan, R., Yan, C., Bai, R., Huang, G., & Shi, Y. (2016) · Science · doi:10.1126/science.aag2235 · Cited by 174
Valacca, C., Bonomi, S., Buratti, E., Pedrotti, S., Baralle, F. E., Sette, C., Ghigna, C., & Biamonti, G. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001073 · Cited by 172
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
Suzuki, H., Kumar, S. A., Shuai, S., Diaz-Navarro, A., Gutierrez-Fernandez, A., De Antonellis, P., Cavalli, F. M. G., Juraschka, K., Farooq, H., Shibahara, I., et al. (2019) · Nature · doi:10.1038/s41586-019-1650-0 · Cited by 172
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Shuai, S., Suzuki, H., Diaz-Navarro, A., Nadeu, F., Kumar, S. A., Gutierrez-Fernandez, A., Delgado, J., Pinyol, M., López-Otín, C., Puente, X. S., et al. (2019) · Nature · doi:10.1038/s41586-019-1651-z · Cited by 171
Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes
Singh, R. N., & Singh, N. N. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_2 · Cited by 167
Chen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093297 · Cited by 165
Babic, I., Anderson, E. S., Tanaka, K., Guo, D., Masui, K., Li, B., Zhu, S., Gu, Y., Villa, G. R., Akhavan, D., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.013 · Cited by 164
The splice of life: Alternative splicing and neurological disease
Dredge, B. K., Polydorides, A. D., & Darnell, R. B. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049061 · Cited by 164
Splicing factor SRSF6 promotes hyperplasia of sensitized skin
Jensen, M. A., Wilkinson, J. E., & Krainer, A. R. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2756 · Cited by 162
The 3.8 Å structure of the U4/U6.U5 tri-snRNP: Insights into spliceosome assembly and catalysis
Wan, R., Yan, C., Bai, R., Wang, L., Huang, M., Wong, C. C. L., & Shi, Y. (2016) · Science · doi:10.1126/science.aad6466 · Cited by 159
Unusual Processing Generates SPA LncRNAs that Sequester Multiple RNA Binding Proteins
Wu, H., Yin, Q.-F., Luo, Z., Yao, R.-W., Zheng, C.-C., Zhang, J., Xiang, J., Yang, L. C., & Chen, L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.007 · Cited by 159
Modulating splicing with small molecular inhibitors of the spliceosome
Effenberger, K. A., Urabe, V. K., & Jurica, M. S. (2017) · WIREs RNA · doi:10.1002/wrna.1381 · Cited by 158
Splicing factor mutations and cancer
Yoshida, K., & Ogawa, S. (2014) · WIREs RNA · doi:10.1002/wrna.1222 · Cited by 155
Hernández, F., Pérez, M., Lucas, J. J., Mata, A. M., Bhat, R. V., & Ávila, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311512200 · Cited by 152
Antisense oligonucleotides in neurological disorders
Wurster, C. D., & Ludolph, A. C. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418776932 · Cited by 146
Gallardo, M., Lee, H. J., Zhang, X., Bueso-Ramos, C., Pageon, L. R., McArthur, M., Multani, A., Nazha, A., Manshouri, T., Parker-Thornburg, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.001 · Cited by 145
Hatcher, J. M., Wu, G., Zeng, C., Zhu, J., Fan, M., Patel, S. H., Wang, W., Ficarro, S. B., Leggett, A. L., Powell, C. E., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.013 · Cited by 145
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
Sheng, J., Zhao, Q., Zhao, J., Zhang, W., Sun, Y., Qin, P., Lv, Y., Bai, L., Yang, Q., Chen, L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.007 · Cited by 142
Self-citationAnti-tumor activity of splice-switching oligonucleotides
Bauman, J. A., Li, S., Yang, A., Huang, L., & Kole, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq731 · Cited by 141
Papaioannou, D., Petri, A., Dovey, O. M., Terreri, S., Wang, E., Collins, F. A., Woodward, L. A., Walker, A. E., Nicolet, D., Pepe, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13259-2 · Cited by 137
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
Okeyo-Owuor, T., White, B. S., Chatrikhi, R., Mohan, D. R., Kim, S. P., Griffith, M., Ding, L., Ketkar-Kulkarni, S., Hundal, J., Laird, K. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.303 · Cited by 135
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
Shehadeh, L. A., Yu, K. M., Wang, L., Guevara, A., Singer, C., Vance, J. M., & Papapetropoulos, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009104 · Cited by 132
Shultz, J. C., Goehe, R. W., Wijesinghe, D. S., Murudkar, C. S., Hawkins, A. J., Shay, J. W., Minna, J. D., & Chalfant, C. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1545 · Cited by 132
Cooper, D. R., Carter, G., Li, P., Patel, R., Watson, J., & Patel, N. A. (2014) · Genes · doi:10.3390/genes5041050 · Cited by 131
Gordon, M. A., Babbs, B. L., Cochrane, D. R., Bitler, B. G., & Richer, J. K. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22919 · Cited by 129
Phosphorylation-Dependent Regulation of PSF by GSK3 Controls CD45 Alternative Splicing
Heyd, F., & Lynch, K. W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.013 · Cited by 128
Mupo, A., Seiler, M., Sathiaseelan, V., Pance, A., Yang, Y., Agrawal, A. A., Iorio, F., Bautista, R., Pacharne, S., Tzelepis, K., et al. (2016) · Leukemia · doi:10.1038/leu.2016.251 · Cited by 128
Self-citationShilo, A., Ben-Hur, V., Denichenko, P., Stein, I., Pikarsky, E., Rauch, J., Kölch, W., Zender, L., & Karni, R. (2014) · RNA · doi:10.1261/rna.042259.113 · Cited by 127
PRPF8 defects cause missplicing in myeloid malignancies
Kurtović-Kozarić, A., Przychodzen, B. P., Singh, J., Konarska, M. M., Clemente, M. J., Otrock, Z. K., Nakashima, M. O., Hsi, E. D., Yoshida, K., Shiraishi, Y., et al. (2014) · Leukemia · doi:10.1038/leu.2014.144 · Cited by 123
Alternative Splicing as a Target for Cancer Treatment
Martínez-Montiel, N., Rosas-Murrieta, N. H., Anaya-Ruíz, M., Monjaraz-Guzmán, E., & Martínez-Contreras, R. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020545 · Cited by 122
Post-translational modification control of RNA-binding protein hnRNPK function
Xu, Y., Wu, W., Qiu, H., Wang, Y., Li, C., Zhang, P., & Xu, H. (2019) · Open Biology · doi:10.1098/rsob.180239 · Cited by 122
Liu, F., Dai, M., Xu, Q., Zhu, X., Zhou, Y., Jiang, S., Wang, Y., Ai, Z., Ma, L., Zhang, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0119-6 · Cited by 118
Self-citationGonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
The alternative splicing side of cancer
Biamonti, G., Catillo, M., Pignataro, D. S., Montecucco, A., & Ghigna, C. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.016 · Cited by 110
Barbosa‐Morais, N. L., Carmo‐Fonseca, M., & Aparicio, S. A. J. R. (2005) · Genome Research · doi:10.1101/gr.3936206 · Cited by 108
Fan, L., Zhang, F., Xu, S., Cui, X., Hussain, A., Fazli, L., Gleave, M. E., Dong, X., & Qi, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802415115 · Cited by 107
Palangat, M., Anastasakis, D. G., Fei, D. L., Lindblad, K. E., Bradley, R. K., Hourigan, C. S., Hafner, M., & Larson, D. R. (2019) · Genes & Development · doi:10.1101/gad.319590.118 · Cited by 107
MechRNA: prediction of lncRNA mechanisms from RNA–RNA and RNA–protein interactions
Gawronski, A., Uhl, M., Zhang, Y., Lin, Y., Niknafs, Y. S., Ramnarine, V. R., Malik, R., Feng, F. Y.-C., Chinnaiyan, A. M., Collins, C. C., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty208 · Cited by 106
Self-citationLiang, Y., Tebaldi, T., Rejeski, K., Joshi, P. M., Stefani, G., Taylor, A., Song, Y., Vasic, R., Maziarz, J. D., Balasubramanian, K., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0152-7 · Cited by 106
TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
Tripathi, V., Shin, J., Stuelten, C. H., & Zhang, Y. E. (2019) · Oncogene · doi:10.1038/s41388-018-0655-8 · Cited by 106
Self-citationSpecific inhibition of splicing factor activity by decoy RNA oligonucleotides
Denichenko, P., Mogilevsky, M., Cléry, A., Welte, T., Biran, J., Tepper, O., Barnabas, G. D., Danan-Gotthold, M., Kumar, S., Yavin, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09523-0 · Cited by 103
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Taylor, J., & Lee, S. C.-W. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22784 · Cited by 103
Isolation and characterization of the human pyruvate kinase M gene
TAKENAKA, M., Noguchi, T., Sadahiro, S., Hirai, H., Yamada, K., Matsuda, T., Imai, E., & Tanaka, T. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15991.x · Cited by 101
CRISPR–Cas13 Precision Transcriptome Engineering in Cancer
Granados-Riveron, J. T., & Aquino‐Jarquín, G. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0785 · Cited by 100
Xie, R., Chen, X., Chen, Z., Huang, M. X., Dong, W., Gu, P., Zhang, J., Zhou, Q., Dong, W., Han, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.041 · Cited by 100
The Alternative Heart: Impact of Alternative Splicing in Heart Disease
Lara‐Pezzi, E., Gómez-Salinero, J. M., Gatto, A., & García‐Pavía, P. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9482-z · Cited by 99
HOTAIR , a long noncoding RNA , is a marker of abnormal cell cycle regulation in lung cancer
Liu, M., Zhang, H., Li, Y., Wang, R., Li, Y., Zhang, H., Ren, D., Liu, H., Kang, C., & Chen, J. (2018) · Cancer Science · doi:10.1111/cas.13745 · Cited by 96
Bielli, P., Bordi, M., Biasio, V. D., & Sette, C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku922 · Cited by 95
de Fraipont, F., Gazzéri, S., Cho, W. C. S., & Eymin, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00390 · Cited by 95
Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 93
Malakar, P., Chartarifsky, L., Hija, A., Leibowitz, G., Gläser, B., Dor, Y., & Karni, R. (2016) · Scientific Reports · doi:10.1038/srep31222 · Cited by 90
Genome-wide identification of cancer-specific alternative splicing in circRNA
Feng, J. Q., Chen, K., Dong, X., Xu, X., Jin, Y., Zhang, X., Chen, W., Han, Y., Shao, L., Gao, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0996-0 · Cited by 89
The role of alternative splicing in cancer
Singh, B., & Eyras, E. (2016) · Transcription · doi:10.1080/21541264.2016.1268245 · Cited by 86
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Gautrey, H., & Tyson-Capper, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051497 · Cited by 84
Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events
Lin, J.-C., Lin, C., Tarn, W., & Li, F.-Y. (2014) · RNA · doi:10.1261/rna.045583.114 · Cited by 84
Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity
Duriez, M., Mandouri, Y., Lekbaby, B., Wang, H., Schnuriger, A., Redelsperger, F., Guerrera, I. C., Lefèvre, M., Fauveau, V., Ahodantin, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.025 · Cited by 84
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
Harvey, S. E., Xu, Y., Lin, X., Gao, X. D., Qiu, Y., Ahn, J., Xiao, X. G., & Cheng, C. (2018) · RNA · doi:10.1261/rna.066712.118 · Cited by 81
Visconte, V., Nakashima, M. O., & Rogers, H. J. (2019) · Cancers · doi:10.3390/cancers11121844 · Cited by 80
Alternative Splicing in Alzheimer’s Disease
Love, J. E., Hayden, E. J., & Rohn, T. T. (2015) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000010 · Cited by 79
Targeting splicing abnormalities in cancer
Agrawal, A. A., Yu, L., Smith, P. G., & Buonamici, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.010 · Cited by 79
Schischlik, F., Jäger, R., Rosebrock, F., Hug, E., Schuster, M. K., Holly, R., Fuchs, E., Feenstra, J. D. M., Bogner, E., Gisslinger, B., et al. (2019) · Blood · doi:10.1182/blood.2019000519 · Cited by 79
Wang, F., Fu, X., Chen, P., Wu, P., Fan, X., Li, N., Zhu, H. M., Jia, T.-T., Ji, H., Wang, Z., et al. (2017) · Cell Research · doi:10.1038/cr.2017.7 · Cited by 77
Serena, G., Yan, S., Camhi, S. S., Patel, S., Lima, R. S., Sapone, A., Leonard, M. M., Mukherjee, R., Nath, B. J., Lammers, K. M., et al. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12911 · Cited by 77
The β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression
Gonçalves, V., Matos, P., & Jordan, P. (2008) · RNA · doi:10.1261/rna.1253408 · Cited by 75
PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing
Liang, X., Chen, W., Shi, H., Gu, X., Li, Y., Qi, Y., Xu, K., Zhao, A., & Liu, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0608-8 · Cited by 72
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Belluti, S., Rigillo, G., & Imbriano, C. (2020) · Cells · doi:10.3390/cells9030760 · Cited by 72
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Zhu, H., Carpenter, R. L., Han, W., & Lo, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.014 · Cited by 70
Choudhury, R., Roy, S. G., Tsai, Y., Tripathy, A., Graves, L. M., & Wang, Z. (2014) · Nature Communications · doi:10.1038/ncomms4078 · Cited by 70
Splicing Regulators and Their Roles in Cancer Biology and Therapy
da Silva, M. R., Moreira, G. A., da Silva, R. A. G., Barbosa, É. D. A. A., Siqueira, R. P., Teixeira, R. R., de Almeida, M. R., Silva‐Júnior, A., Fietto, J. L. R., & Bressan, G. C. (2015) · BioMed Research International · doi:10.1155/2015/150514 · Cited by 64
Osman, E. Y., Miller, M. R., Robbins, K. L., Lombardi, A., Atkinson, A. K., Brehm, A. J., & Lorson, C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu198 · Cited by 64
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 63
Hollander, D., Donyo, M., Atias, N., Mekahel, K., Melamed, Z., Yannai, S., Lev-Maor, G., Shilo, A., Schwartz, S., Barshack, I., et al. (2016) · Genome Research · doi:10.1101/gr.193169.115 · Cited by 61
Abnormalities in alternative splicing in diabetes: therapeutic targets
Dlamini, Z., Mokoena, F., & Hull, R. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0049 · Cited by 60
Li, Z., Li, Q., HAN, L., Tian, N., Liang, Q., LI, Y., Zhao, X., Du, C., & Tian, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4465 · Cited by 56
Wagner, K., Maï, M. E., Ladomery, M., Belali, T. M., Cardot‐Leccia, N., Michiels, J., & Wagner, N. (2019) · Cells · doi:10.3390/cells8010041 · Cited by 56
Touznik, A., Maruyama, R., Hosoki, K., Echigoya, Y., & Yokota, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03850-2 · Cited by 54
Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia
Liu, J., Huang, B., Xiao, Y., Xiong, H.-M., Li, J., Feng, D.-Q., Chen, X.-M., Zhang, H.-B., & Wang, X.-Z. (2012) · Onkologie · doi:10.1159/000338941 · Cited by 53
Alternative Splicing in Tumors — A Path to Immunogenicity?
Slansky, J. E., & Spellman, P. T. (2019) · New England Journal of Medicine · doi:10.1056/nejmcibr1814237 · Cited by 53
RNA Therapeutics: How Far Have We Gone?
Coutinho, M. F., Matos, L., Santos, J. I., & Alves, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-19966-1_7 · Cited by 52
Kanagal‐Shamanna, R., Luthra, R., Yin, C. C., Patel, K. P., Takahashi, K., Lu, X. Y., Lee, J., Zhao, C., Stingo, F. C., Zuo, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7350 · Cited by 51
Peiqi, L., Zhaozhong, G., Yaotian, Y., Jun, J., Jihua, G., & Rong, J. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.14871 · Cited by 51
RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway
Jin, X., Di, X., Wang, R., Ma, H., Tian, C., Zhao, M., Cong, S., Liu, J., Li, R., & Wang, K. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14263 · Cited by 51
Huang, H. H., Ferguson, I., Thornton, A. M., Bastola, P., Lam, C., Lin, Y.-H. T., Choudhry, P., Mariano, M. C., Marcoulis, M., Teo, C. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15521-4 · Cited by 51
Modulation of Alternative Splicing with Chemical Compounds in New Therapeutics for Human Diseases
Ohe, K., & Hagiwara, M. (2015) · ACS Chemical Biology · doi:10.1021/cb500697f · Cited by 50
The Role of RNA Structure in Posttranscriptional Regulation of Gene Expression
Jacobs, E. A. K., Mills, J. D., & Janitz, M. (2012) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.08.002 · Cited by 48
Gray, P., Michelsen, K. S., Sirois, C. M., Lowe, E. L., Shimada, K., Crother, T. R., Chen, S., Brikos, C., Bulut, Y., Latz, E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903543 · Cited by 47
Alieva, A. K., Shadrina, M. I., Filatova, E. V., Karabanov, A. V., Illarioshkin, S. N., Limborska, S. A., & Slominsky, P. A. (2014) · BioMed Research International · doi:10.1155/2014/718732 · Cited by 47
Volpe, G., Cignetti, A., Panuzzo, C., Kuka, M., Vitaggio, K., Brancaccio, M., Perrone, G., Rinaldi, M., Prato, G., Fava, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3737 · Cited by 47
CD20 alternative splicing isoform generates immunogenic CD 4 helper T epitopes
Vauchy, C., Gamonet, C., Ferrand, C., Daguindau, É., Galaine, J., Beziaud, L., Chauchet, A., Henry, C., Deschamps, M., Rohrlich, P., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29366 · Cited by 45
Hughes, T., Hansson, L. J., Sønderby, I. E., Athanasiu, L., Zuber, V., Tesli, M., Song, J., Hultman, C. M., Bergen, S. E., Landén, M., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.021 · Cited by 45
Jafari, P. A., Ayatollahi, H., Sadeghi, R., Sheikhi, M., & Asghari, A. (2018) · Hematology · doi:10.1080/10245332.2018.1471794 · Cited by 45
Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis
Lin, P., He, R., Huang, Z., Zhang, R., Wu, H., Shi, L., Li, X., Li, Q., Chen, G., Yang, H., et al. (2019) · Aging · doi:10.18632/aging.101902 · Cited by 43
Faulty splicing and cytoskeleton abnormalities in Huntington's disease
Fernández‐Nogales, M., Santos‐Galindo, M., Hernández, I. H., Cabrera, J. R., & Lucas, J. J. (2016) · Brain Pathology · doi:10.1111/bpa.12430 · Cited by 41
Differential Impacts of Alternative Splicing Networks on Apoptosis
Lin, J.-C., Tsao, M.-F., & Lin, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122097 · Cited by 41
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
Yoshimi, A., & Abdel-Wahab, O. I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0131 · Cited by 40
Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
Dahal, L. N., Basu, N., Youssef, H. M., Khanolkar, R. C., Barker, R. N., Erwig, L. P., & Ward, F. J. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1075-1 · Cited by 38
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas
Gallardo, M., Malaney, P., Aitken, M. J. L., Zhang, X., Link, T. M., Shah, V. V., Alybayev, S., Wu, M., Pageon, L. R., Ma, H., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz078 · Cited by 38
Alternative Splicing and Its Impact as a Cancer Diagnostic Marker
Kim, Y.-J., & Kim, H. (2012) · Genomics & Informatics · doi:10.5808/gi.2012.10.2.74 · Cited by 37
Sokół, E., Kędzierska, H., Czubaty, A., Rybicka, B., Rodzik, K., Tański, Z., Bogusławska, J., & Piekiełko‐Witkowska, A. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.009 · Cited by 33
Wang, Q., Wang, F., Zhong, W., et al. (2019) · Gene · doi:10.1016/j.gene.2019.02.025 · Cited by 33
miR‐335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer
Dou, X., Chen, X., Zhou, Q. Y., Wen, M., Zhang, S., & Zhang, S. (2020) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12149 · Cited by 32
Functional role of RBM10 in lung adenocarcinoma proliferation
Sun, X., Jia, M., Sun, W., Lu, F., Gu, C., & Wu, T. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4643 · Cited by 31
Self-citationRNA in spinal muscular atrophy: therapeutic implications of targeting
Singh, R. N., Seo, J., & Singh, N. N. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1783241 · Cited by 30
The Epithelial Sodium Channel in Hypertension
Swift, P. A., & MacGregor, G. A. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404030-00003 · Cited by 30
Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction
Ohno, K., Rahman, M. A., Nazim, M., Nasrin, F., Lin, Y., Takeda, J., & Masuda, A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13954 · Cited by 28
MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication
Liu, S., Zhao, K., Su, X., Lu, L., Zhao, H., Zhang, X., Wang, Y., Wu, C., Chen, J., Zhou, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169701 · Cited by 24
Cited by
Deep Visual Proteomics defines single-cell identity and heterogeneity
Mund, A., Coscia, F., Kriston, A., Hollandi, R., Kovács, F., Brunner, A.-D., Migh, E., Schweizer, L., Santos, A., Bzorek, M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01302-5 · Cited by 562
Alternative splicing and related RNA binding proteins in human health and disease
Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01734-2 · Cited by 320
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zhang, Z., Lu, M., Qin, Y., Gao, W., Tao, L., Su, W., & Zhong, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672356 · Cited by 284
Rammohan, M., Harris, E., Bhansali, R. S., Zhao, E., Li, L. S., & Crispino, J. D. (2022) · Oncogene · doi:10.1038/s41388-022-02245-6 · Cited by 68
Challenges in Therapeutically Targeting the RNA‐Recognition Motif
Schmeing, S., & Hart, P. '. (2024) · WIREs RNA · doi:10.1002/wrna.1877 · Cited by 11
Metadata
- Authors
- Zhang, Y., Qian, J., Gu, C., & Yang, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-02-24
- Volume
- 6
- Issue
- 1
- Pages
- 78-78
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3132948359
- Cited by
- 497
- References
- 209
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.